Provided by Tiger Trade Technology Pte. Ltd.

City Therapeutics

22.40
+4.4024.44%
Post-market: 21.72-0.6793-3.03%19:58 EDT
Volume:1.41M
Turnover:31.09M
Market Cap:1.13B
PE:-12.86
High:23.88
Open:23.00
Low:20.50
Close:18.00
52wk High:23.88
52wk Low:20.50
Shares:50.33M
Float Shares:9.70M
Volume Ratio:- -
T/O Rate:14.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7420
ROE:--
ROA:--
PB:-8.56
PE(LYR):- -

Loading ...

Company Profile

Company Name:
City Therapeutics
Exchange:
NASDAQ
Establishment Date:
2023
Employees:
75
Office Location:
399 Binney Street,Cambridge,Massachusetts,United States
Zip Code:
02142
Fax:
- -
Introduction:
City Therapeutics, Inc. is a clinical-stage biotechnology company developing next-generation RNA interference (RNAi) medicines designed to selectively silence disease-associated proteins. Its pipeline focuses on conditions with significant unmet medical needs, including thromboembolic disease, Stargardt disease type 1, and chronic anemia.

Directors

Name
Position
Andrew Orth
Chief Executive Officer and Director and President
John Maraganore
Director and Executive Chairman of the Board
Barry Greene
Director
Robert Nelsen
Director
Ron Philip
Director
Saraswathy V. Nochur
Director

Shareholders

Name
Position
Andrew Orth
Chief Executive Officer and Director and President
Sebastian Trousil
Chief Operating Officer
Keith Regnante
Chief Financial Officer
Baisong Mei
Chief Medical Officer
John Maraganore
Director and Executive Chairman of the Board
Tracy Zimmermann
Chief Scientific Officer